S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities

Aridis Pharmaceuticals (ARDS) Earnings Date, Estimates & Call Transcripts

$0.06
0.00 (0.00%)
(As of 04/18/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

ARDS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ARDS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aridis Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:$0.07 EPS
Next Year EPS Consensus Estimate: ($0.09) EPS

ARDS Earnings Date and Information

Aridis Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Aridis Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)
------- 
11/6/2023Q3 2023-($0.02)($0.02)($0.04)-$0.42 million
9/13/2023Q2 2023-$0.33+$0.33$0.33-$19.65 million
6/8/2023Q1 2023-($0.22)($0.22)($0.22)-$1.08 million
5/22/2023Q4 2022-($0.27)($0.27)($0.27)-$1.21 million
11/21/2022Q3 2022($0.01)($0.42)($0.41)($0.37)$11.20 million$0.40 million
8/16/2022Q2 2022($0.06)($0.45)($0.39)($0.45)$10.47 million$0.29 million
5/16/2022Q1 2022($0.51)($0.44)+$0.07($0.44)$2.00 million$1.19 million
3/31/2022Q4 2021($0.58)($0.92)($0.34)($0.92)$5.70 million$0.57 million
11/10/2021Q3 2021($0.51)($1.94)($1.43)($1.94)-$0.52 million
8/11/2021Q2 2021($0.63)($0.55)+$0.08($0.61)$0.40 million$0.03 million    
5/11/2021Q1 2021($0.60)($0.77)($0.17)($0.77)--

Aridis Pharmaceuticals Earnings - Frequently Asked Questions

When is Aridis Pharmaceuticals's earnings date?

Aridis Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on ARDS's earnings history.

How much revenue does Aridis Pharmaceuticals generate each year?

Aridis Pharmaceuticals (NASDAQ:ARDS) has a recorded annual revenue of $3.09 million.

How much profit does Aridis Pharmaceuticals generate each year?

Aridis Pharmaceuticals (NASDAQ:ARDS) has a recorded net income of -$30.37 million. ARDS has generated -$0.16 earnings per share over the last four quarters.

What is Aridis Pharmaceuticals's EPS forecast for next year?

Aridis Pharmaceuticals's earnings are expected to decrease from $0.07 per share to ($0.09) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ARDS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners